Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06372717
Title A Study to Investigate APL-4098 Alone and/or in Combination With Azacitidine in R/R AML and High-Risk MDS
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Apollo Therapeutics Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS


No variant requirements are available.